Danske Bank’s BeOne Medicines Ltd ONC Stock Holding History

Danske Bank’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,300	Closed	-$2.24M	–	1268
2024 Q1	$2.24M	Buy	+14,300	New	+$2.3M	0.01%	671

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Danske Bank's ONC Position: Q2 2024 in Review

Danske Bank sold out of BeOne Medicines Ltd (ONC) in Q2 2024, closing a stake of 14,300 shares — an estimated $2.24M sold.

Danske Bank first reported a position in ONC in Q1 2024 and held it in 1 quarter. The position peaked at $2.24M in Q1 2024. 200 funds tracked by Wall St. Rank hold ONC as of Q2 2024.

Danske Bank reported no remaining BeOne Medicines Ltd position as of Q2 2024 after selling out during the quarter.
Danske Bank sold 14,300 BeOne Medicines Ltd shares in Q2 2024, an estimated $2.24M.
Danske Bank first reported a position in BeOne Medicines Ltd in Q1 2024 and held it in 1 quarter.
Danske Bank's BeOne Medicines Ltd position peaked at $2.24M in Q1 2024.
200 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2024.

Based on Danske Bank's 13F filing for Q2 2024, filed 18 Mar 2026.